Nath Bio-Genes (India) Limited
Symbol: NATHBIOGEN.NS
NSE
195
INRDzisiejsza cena rynkowa
9.0886
Wskaźnik P/E
2.0302
Wskaźnik PEG
3.71B
Kapitalizacja MRK
- 0.02%
Rentowność DIV
Nath Bio-Genes (India) Limited (NATHBIOGEN-NS) Sprawozdania finansowe
Bilans
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 2089.2 | 41.7 | 292.1 | ||||||||||||
balance-sheet.row.short-term-investments | 0 | 1709.3 | 0.2 | 0 | ||||||||||||
balance-sheet.row.net-receivables | 0 | 1033.6 | 2456.6 | 2683.8 | ||||||||||||
balance-sheet.row.inventory | 0 | 2078.5 | 2203.4 | 2263 | ||||||||||||
balance-sheet.row.other-current-assets | 0 | 7 | 0 | 0 | ||||||||||||
balance-sheet.row.total-current-assets | 0 | 5208.3 | 4701.7 | 5238.9 | ||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 2339.6 | 2328.5 | 2333 | ||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.intangible-assets | 0 | 104.2 | 120.3 | 136.2 | ||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 104.2 | 120.3 | 136.2 | ||||||||||||
balance-sheet.row.long-term-investments | 0 | 50.5 | 50.5 | 50.5 | ||||||||||||
balance-sheet.row.tax-assets | 0 | 0 | 218.1 | 136.5 | ||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 225.4 | 0 | 0 | ||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 2719.7 | 2717.4 | 2656.2 | ||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.total-assets | 0 | 7928 | 7419.1 | 7895.1 | ||||||||||||
balance-sheet.row.account-payables | 0 | 277.4 | 550.9 | 452.3 | ||||||||||||
balance-sheet.row.short-term-debt | 0 | 1048.1 | 922.9 | 959.1 | ||||||||||||
balance-sheet.row.tax-payables | 0 | 2.8 | 8.9 | 25.3 | ||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 4 | 6.6 | 6.5 | ||||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||
balance-sheet.row.other-current-liab | 0 | 830.4 | 63.6 | 0 | ||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 31.7 | 32.8 | 32.3 | ||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.total-liab | 0 | 2196.2 | 1999.4 | 1762.3 | ||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.common-stock | 0 | 190 | 190 | 190 | ||||||||||||
balance-sheet.row.retained-earnings | 0 | 4056.6 | 3744.7 | 4456.1 | ||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 150.1 | 149.9 | 151.6 | ||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 1335 | 1335 | 1335 | ||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 5731.7 | 5419.7 | 6132.8 | ||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 7928 | 7419.1 | 7895.1 | ||||||||||||
balance-sheet.row.minority-interest | 0 | -0.2 | 0 | 0 | ||||||||||||
balance-sheet.row.total-equity | 0 | 5731.5 | 5419.6 | 6132.8 | ||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||||
Total Investments | 0 | 50.5 | 50.6 | 50.5 | ||||||||||||
balance-sheet.row.total-debt | 0 | 1052.1 | 929.6 | 965.7 | ||||||||||||
balance-sheet.row.net-debt | 0 | 672.2 | 887.9 | 673.6 |
Rachunek przepływów pieniężnych
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 361.6 | -633.9 | 567.5 | |||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 30.1 | 30.8 | 28.2 | |||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.change-in-working-capital | 0 | -98.1 | -180.7 | -651.3 | |||||||||||
cash-flows.row.account-receivables | 0 | -118.8 | 210.2 | -20.6 | |||||||||||
cash-flows.row.inventory | 0 | 125 | 59.6 | -219.9 | |||||||||||
cash-flows.row.account-payables | 0 | -150.5 | 199.9 | -229.7 | |||||||||||
cash-flows.row.other-working-capital | 0 | 46.2 | -650.4 | -181.1 | |||||||||||
cash-flows.row.other-non-cash-items | 0 | 90 | 954.2 | 66.7 | |||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -25.5 | -210.2 | -116 | |||||||||||
cash-flows.row.acquisitions-net | 0 | 0.5 | 0.7 | 1.5 | |||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | -0.2 | -0.5 | |||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | -0.5 | -0.7 | -1.5 | |||||||||||
cash-flows.row.other-investing-activites | 0 | -3.4 | 11.7 | 13.7 | |||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -28.8 | -198.7 | -102.8 | |||||||||||
cash-flows.row.debt-repayment | 0 | -122.5 | -78.2 | -252.2 | |||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.dividends-paid | 0 | -38 | -38 | 0 | |||||||||||
cash-flows.row.other-financing-activites | 0 | 143.9 | -106.1 | 416.2 | |||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -16.7 | -222.3 | 164 | |||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0.1 | 0 | |||||||||||
cash-flows.row.net-change-in-cash | 0 | 338.1 | -250.5 | 72.3 | |||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 380 | 41.7 | 292.2 | |||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 41.8 | 292.2 | 219.8 | |||||||||||
cash-flows.row.operating-cash-flow | 0 | 383.7 | 170.5 | 11.1 | |||||||||||
cash-flows.row.capital-expenditure | 0 | -25.5 | -210.2 | -116 | |||||||||||
cash-flows.row.free-cash-flow | 0 | 358.2 | -39.7 | -104.9 |
Wiersz rachunku zysków i strat
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 3326.2 | 3012.9 | 2783.6 | |||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 1650.8 | 1345.9 | 1239.7 | |||||||||||||
income-statement-row.row.gross-profit | 0 | 1675.4 | 1667 | 1543.9 | |||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||
income-statement-row.row.other-expenses | 0 | 0 | 5.6 | 1 | |||||||||||||
income-statement-row.row.operating-expenses | 0 | 1209.4 | 1208.2 | 1197.4 | |||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 2860.2 | 2554.1 | 2437 | |||||||||||||
income-statement-row.row.interest-income | 0 | 0 | 0.2 | 10.9 | |||||||||||||
income-statement-row.row.interest-expense | 0 | 91.1 | 101.2 | 101.3 | |||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -84.8 | -95.7 | -980 | |||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 0 | 5.6 | 1 | |||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -84.8 | -95.7 | -980 | |||||||||||||
income-statement-row.row.interest-expense | 0 | 91.1 | 101.2 | 101.3 | |||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 32.6 | 30.1 | 30.8 | |||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||||
income-statement-row.row.operating-income | 0 | 466 | 457.3 | 345.7 | |||||||||||||
income-statement-row.row.income-before-tax | 0 | 381.2 | 363.2 | -633.9 | |||||||||||||
income-statement-row.row.income-tax-expense | 0 | 19.5 | 11.5 | 39.5 | |||||||||||||
income-statement-row.row.net-income | 0 | 361.7 | 350.1 | -673.4 |
Często zadawane pytania
Ile wynosi Nath Bio-Genes (India) Limited (NATHBIOGEN.NS) aktywów ogółem?
Nath Bio-Genes (India) Limited (NATHBIOGEN.NS) całkowite aktywa to 7927970000.000.
Jaki jest roczny przychód przedsiębiorstwa?
Roczny przychód to N/A.
Jaka jest marża zysku firmy?
Marża zysku firmy to 0.528.
Czym są wolne przepływy pieniężne firmy?
Wolne przepływy pieniężne to 3.442.
Jaka jest marża zysku netto przedsiębiorstwa?
Marża zysku netto to 0.121.
Jaki jest całkowity przychód firmy?
Całkowity przychód to 0.147.
Co to jest Nath Bio-Genes (India) Limited (NATHBIOGEN.NS) zysk netto (dochód netto)?
Zysk netto (dochód netto) wynosi 361697000.000.
Jakie jest całkowite zadłużenie firmy?
Całkowite zadłużenie to 1052123000.000.
Ile wynoszą koszty operacyjne?
Wydatki operacyjne to 1209402000.000.
Jaka jest wartość gotówki firmy?
Środki pieniężne przedsiębiorstwa to 0.000.